LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Melanoma Development Linked to Relationship Between Pigment Synthesis and Mitochondrial Function

By LabMedica International staff writers
Posted on 11 Jan 2015
Print article
Image: Melanin pigment (light refracting granular material - center of image) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
Image: Melanin pigment (light refracting granular material - center of image) in a pigmented melanoma (Photo courtesy of Wikimedia Commons).
Development of melanoma, a potentially fatal type of skin cancer, is linked to the direct relationship between pigment production (melanogenesis) and generation of reactive oxygen species (ROS) by the mitochondria.

Melanogenesis is a highly conserved process in many species that protects cells from UV radiation damage. Although both mitochondrial function and UV radiation damage are well-documented promoters of increased cellular stress, their individual molecular relationships with skin pigmentation have not been clearly resolved.

Investigators at the University of Newcastle (United Kingdom) presented evidence for a direct relationship between cellular melanin content, superoxide flux, and mitochondrial function at Complex II. They examined three types of melanoma skin cancer cell lines that displayed low, medium, or high pigment levels and analyzed their ROS levels and mitochondrial Complex II function.

Results showed that the darker the cells, the higher ROS generation and Complex II function. When cells with lower melanin levels were induced to produce more by augmenting them with L-tyrosine, a building block for melanin production, these cell types gradually exhibited higher pigment levels, while simultaneously showing increased Complex II function.

"This study reports a novel correlation between proteins involved in the bioenergy process within the human skin (i.e., Complex II) and skin pigmentation," said Dr. Mark Birch-Machin, professor of molecular dermatology at Newcastle University. "This leads to interesting possibilities of Complex II playing a central role in coupling stress sensing and cellular adaptation via ROS signaling, and as this study was performed in skin cancer cells, may help in the development of anticancer drugs."

The study was published in the January 2015 issue of the FASEB Journal.

Related Links:

University of Newcastle


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more